Serum concentration of vascular endothelial growth factor cannot predict the course of severe ovarian hyperstimulation syndrome

Human Reproduction

Volumn 13, Issue 1, 1998, Pages 30-32

  Ludwig, M ^a   Bauer, O ^a   Lopens, A ^a   Jelkmann, W ^a   Diedrich, K ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

VEGF OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; VASCULOTROPIN;

ARTICLE; ASCITES; BLOOD LEVEL; BODY WEIGHT; CLINICAL ARTICLE; DISEASE COURSE; DISEASE SEVERITY; ESTRADIOL BLOOD LEVEL; FEMALE; FLUID BALANCE; HEMATOCRIT; HUMAN; OVARY DISEASE; OVARY HYPERSTIMULATION; PATHOGENESIS; PLEURA EFFUSION; PROSPECTIVE STUDY;

FALLOPIA;

EID: 0031933084     PISSN: 02681161     EISSN: None     Source Type: Journal    
DOI: 10.1093/humrep/13.1.30     Document Type: Article

References (14)

1. Abramov, Y., Barak, V., Nisman, B. and Schenker, J.G. (1997) Vascular endothelial growth factor plasma levels correlate to the clinical picture in severe ovarian hyperstimulation syndrome. Fertil. Steril., 67, 261-265.
2. Elchalal, U. and Schenker, J.G. (1997) The pathophysiology of ovarian hyperstimulation syndrome-views and ideas. Hum. Reprod., 12, 1129-1137.
3. Ferrara, N., Houck, K., Jakeman, L.B. et al. (1991) The vascular endothelial growth factor family of polypeptides. J. Cell Biol., 47, 211-218.
4. Heits, F., Katschinski, D.M., Wiedemann, G.J. et al. (1997) Serum vascular endothelial growth factor (VEGF), a prognostic indicator in sarcoma and carcinoma patients. Int. J. Oncol. 10, 333-337.
5. Hyder, S.M., Stancel, G.M., Chiapetta, C. et al. (1996) Uterine expression of vascular endothelial growth factor is increased by oestradiol and tamoxifen. Cancer Res., 56, 3954-3960.
6. Krasnow, J.S., Berga, S.L., Guzick, D.S. et al. (1996) Vascular permeability factor and vascular endothelial growth factor in ovarian hyperstimulation syndrome: a preliminary report. Fertil. Steril., 65, 552-555.
7. McClure, N., Healy, D.L., Rogers, P.A. et al. (1994) Vascular endothelial growth factor as capillary permeability agens in ovarian hyperstimulation syndrome. Lancet, 344, 235-236.
8. McLaren, J., Prentice, A., Charnock Jones, D.S. and Smith, S.K. (1996a) Vascular endothelial growth factor (VEGF) concentrations are elevated in peritoneal fluid of women with endometriosis. Hum. Reprod., 11, 220-223.
9. McLaren, J., Prentice, A., Charnock-Jones, D.S. et al. (1996b) Vascular endothelial growth factor is produced by peritoneal fluid macrophages in endometriosis and is regulated by ovarian steroids. J. Clin. Invest., 98, 482-489.
10. Neulen, J., Yan, Z., Raczek, S. et al. (1995) Human chorionic gonadotropin-dependent expression of vascular endothelial growth factor/vascular permeability factor in human granulosa cells: importance in ovarian hyperstimulation syndrome. J. Clin. Endocrinol. Metab., 80, 1967-1971.
11. Robertson, D., Selleck, K., Suikkari, A.M. et al. (1995) Urinary vascular endothelial growth factor concentrations in women undergoing gonadotrophin treatment. Hum. Reprod., 10, 2478-2482.
12. Schenker, J.G. and Ezra, Y. (1994) Complications of assisted reproductive techniques. Fertil. Steril., 61, 411-422.
13. WHO (1973) Agents Stimulating Gonadal Function in Human. WHO Technical Report Series 514, Geneva.
14. Yan, Z., Weich, H.A., Bernart, W. et al. (1993) Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. J. Clin. Endocrinol. Metab., 77, 1723-1725.